Comparison of fidaxomicin to oral vancomycin for the treatment of Clostridioides difficile infection in hospitalized patients

Comparison of fidaxomicin to oral vancomycin for the treatment of Clostridioides difficile infection in hospitalized patients

Background: Clostridioides difficile infection (CDI) is a major source of morbidity and mortality. Even after recovery, recurrent CDI (rCDI) occurs frequently, and concomitant antibiotic use for treatment of a concurrent non–C. difficile infection is a major risk factor. Treatment with fidaxomicin v...

Full description

Bibliographic Details
Main Authors: A. Krishna Rao, Qianzi Zhao, Jay Krishnan, Justin Bell, Oryan Henig, Jolene Daniel, Kara Sawaya, Owen Albin, John Mills, Lindsay Petty, Kevin Gregg, Daniel Kaul, Anurag Malani, Jason Pogue, Keith Kaye
Format: Article
Language:English
Published: Cambridge University Press 2022-07-01
Series:Antimicrobial Stewardship & Healthcare Epidemiology
Online Access:https://www.cambridge.org/core/product/identifier/S2732494X22001954/type/journal_article

Internet

https://www.cambridge.org/core/product/identifier/S2732494X22001954/type/journal_article

Similar Items